These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 7735170)
1. A single-injection, two-sample method for measuring renal 99mTc-MAG3 clearance in both children and adults. Russell CD; Taylor AT; Dubovsky EV; Eshima D Nucl Med Biol; 1995 Jan; 22(1):55-60. PubMed ID: 7735170 [TBL] [Abstract][Full Text] [Related]
2. A Bayesian 3-compartment model for 99mTc-MAG3 clearance. Russell CD J Nucl Med; 2003 Aug; 44(8):1357-61. PubMed ID: 12902428 [TBL] [Abstract][Full Text] [Related]
3. Measurement of renal function with technetium-99m-MAG3 in children and adults. Russell CD; Taylor AT; Dubovsky EV J Nucl Med; 1996 Apr; 37(4):588-93. PubMed ID: 8691246 [TBL] [Abstract][Full Text] [Related]
4. Effect of arteriovenous difference in measuring renal function by single-injection plasma clearance: role of bolus. Russell CD; Dubovsky EV Nucl Med Biol; 1999 Aug; 26(6):699-705. PubMed ID: 10587110 [TBL] [Abstract][Full Text] [Related]
5. A comparison of single plasma sample methods to estimate renal clearance using 99mTc-ethylenedicysteine and 99mTc-mercaptoacetyltriglycine. Sohaib M; Rafique A; Saeed S; Afshan A Clin Physiol Funct Imaging; 2013 Sep; 33(5):353-8. PubMed ID: 23701132 [TBL] [Abstract][Full Text] [Related]
6. Reproducibility of technetium-99m mercaptoacetyltriglycine clearance in patients with impaired renal function. Erdil TY; Dede F; Tuglular S; Sen F; Ones T; Farsakoglu Z; Inanir S; Ozener C; Akoglu E; Turoglu T Nucl Med Commun; 2006 Feb; 27(2):191-6. PubMed ID: 16404234 [TBL] [Abstract][Full Text] [Related]
7. Radiopharmacokinetics, renal clearance and dosimetry of 99mTc-MAG3. Arteaga de Murphy C; Molina-Trinidad E; Meléndez-Alafort L; Ferro-Flores G; Reyes-Herrera L; Sepúlveda-Méndez J; Sandoval-Guzmán B; Hoyo-Vadillo C Arch Med Res; 1999; 30(1):49-54. PubMed ID: 10071425 [TBL] [Abstract][Full Text] [Related]
8. Estimation of technetium-99m-MAG3 renal clearance in children: two gamma camera techniques compared with multiple plasma samples. Gordon I; Anderson PJ; Orton M; Evans K J Nucl Med; 1991 Sep; 32(9):1704-8. PubMed ID: 1831838 [TBL] [Abstract][Full Text] [Related]
9. Technetium-99m DTPA dimethyl ester: a renal function imaging agent. Comparative studies in animals with technetium-99m mercaptoacetyl triglycine and 131I-ortho-iodohippurate. Bhowal K; Bhattacharyya S; Majumdar A; Giri C; Vanaja R; Ramamoorthy N; Ganguly S; Sarkar BR; Banerjee S; Chatterjee Debnath M Nucl Med Commun; 2003 May; 24(5):583-95. PubMed ID: 12717078 [TBL] [Abstract][Full Text] [Related]
11. [Application of measuring 99mTc-MAG3 plasma clearance based on one-compartment model (MPC method) to pediatric patients]. Koizumi K; Higashida K; Arbab AS; Toyama K; Arai T; Yoshitomi T Kaku Igaku; 1997 Apr; 34(4):259-65. PubMed ID: 9183150 [TBL] [Abstract][Full Text] [Related]
12. Renal uptakes of 99mTc-MAG3, 99mTc-DTPA, and 99mTc-DMSA in rabbits with unilateral ureteral obstruction. Lee WG; Kim JH; Kim JM; Shim KM; Kang SS; Chae HI; Choi SH In Vivo; 2010; 24(2):137-9. PubMed ID: 20363984 [TBL] [Abstract][Full Text] [Related]
13. Renal and extrarenal clearance of 99mTc-MAG3: a comparison with 125I-OIH and 51Cr-EDTA in patients representing all levels of glomerular filtration rate. Rehling M; Nielsen BV; Pedersen EB; Nielsen LE; Hansen HE; Bacher T Eur J Nucl Med; 1995 Dec; 22(12):1379-84. PubMed ID: 8586082 [TBL] [Abstract][Full Text] [Related]
15. Technetium-99m mercaptoacetyltriglycine clearance values in children with minimal renal disease: can a normal range be determined? Meyer G; Piepsz A; Kolinska J; Lepej J; Sixt R; Hahn K Eur J Nucl Med; 1998 Jul; 25(7):760-5. PubMed ID: 9662599 [TBL] [Abstract][Full Text] [Related]
16. What proportion of isotope injected does the child receive in dynamic renal scanning? O'Reilly MA; Gordon I; Thomas H; MacDonald B Nucl Med Commun; 1992 Jun; 13(6):450-3. PubMed ID: 1306656 [TBL] [Abstract][Full Text] [Related]
17. Prospective validation of a single sample technique to determine technetium-99m-MAG3 clearance. Taylor A; Corrigan P; Eshima D; Folks R J Nucl Med; 1992 Sep; 33(9):1620-2. PubMed ID: 1387682 [TBL] [Abstract][Full Text] [Related]
18. Effect of renal maturation on the clearance of technetium-99m mercaptoacetyltriglycine. Lythgoe MF; Gordon I; Anderson PJ Eur J Nucl Med; 1994 Dec; 21(12):1333-7. PubMed ID: 7875172 [TBL] [Abstract][Full Text] [Related]
19. [Advantages of the new radiopharmaceutic agent, 99mTC-mercaptoacetyltriglycine (99mTc-MAG3), in the diagnosis of kidneydiseases. A comparative study with 131I-OIH, 99mTc-DTPA and 99mTc-DMSA]. Lepej J; Marosová A; Kliment J; Buchanec J; Svitác J; Klisenbauer L Bratisl Lek Listy; 1992 May; 93(5):258-65. PubMed ID: 1327424 [TBL] [Abstract][Full Text] [Related]
20. Optimum sample times for single-injection, multisample renal clearance methods. Russell CD J Nucl Med; 1993 Oct; 34(10):1761-5. PubMed ID: 8410295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]